Official 2023 U.S. DOL Form 5500 summary for Galephar Pharmaceutical Research INC (Galephar Pharmaceutical Retirement Plan · EIN 66-0965645 · PN 001): $222,035 net assets, 121 active participants, and $209.61 per $10,000 (209.61 bps).
| Plan Sponsor | Galephar Pharmaceutical Research INC |
|---|---|
| Filing Identifier | Galephar Pharmaceutical Retirement Plan · EIN 66-0965645 · PN 001 |
| Plan Category & State | 401(k) Defined Contribution (PR) |
| Asset-Size Peer Cohort | <$1M |
| Plan Net Assets (2023) | $222,035 |
| Active Participants | 121 |
| Direct Admin Fee Rate | $209.61 per $10,000 (209.61 bps) |
| Cohort Peer Median | N/A |
| Primary Recordkeeper / Provider | Empower Retirement |
| Schedule H Line 4a Remittance | Schedule H Line 4a Late Remittance Reported ($26,458, often administrative timing) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI